t
Ilika plc announced on March 10, 2026, the successful completion of its initial commercial delivery of Stereax® electrode. This delivery was made to Cirtec Medical and represents Ilika's first revenue-generating order from Cirtec, following the initiation of their commercial electrode supply arrangement in January 2026.
| Date | 10 Mar 2026 |
| Time | 07:00:10 |
| Category | Miscellaneous |
| ID | 9246V |
10 March 2026
Ilika plc
('Ilika,' the 'Company,' or the 'Group')
Ilika Announces Completion of First Commercial Delivery to Cirtec Medical
Electrode delivery signals further commercial progress
Ilika (AIM: IKA), the UK pioneer in solid state battery technology, announces it has successfully delivered its initial batch of commercial grade StereaxÒ electrode to Cirtec Medical (Cirtec) for Stereax M300 production.
In January 2026, Ilika that Cirtec had initiated the commercial electrode supply arrangement with Ilika to support product manufacturing. Ilika has now fulfilled the initial order, its first revenue-generating order from Cirtec.
The electrodes will be used in Stereax M300 batteries for validation and customer sampling across a wide range of active implantable medical device (AIMD) applications, including powering implanted sensors, neurostimulators, orthopaedic implants, orthodontic wearables and ophthalmology devices.
Shawn Martin, Vice President at Cirtec Medical, said: "Our close technical cooperation with Ilika has developed into an effective operational partnership, ensuring our customers will receive the highest quality product for integration into their devices. "
Graeme Purdy, CEO of Ilika, said: "This milestone demonstrates that Ilika's facility in the UK can deliver commercial-grade electrodes to support Cirtec's M300 manufacturing activities. We look forward to ramping our supply activities to meet customer demand."
ENDS--
Enquiries:
|
Ilika Plc Jason Stewart, Chief Financial Officer
|
Via FTI Consulting |
|
|
|
|
Cavendish Capital Markets Limited (Nomad and Broker) Neil McDonald
|
+44 (0)131 220 9771 |
|
|
|
|
FTI Consulting (Comms Advisors) Ben Brewerton Elizabeth Adams Dwight Burden |
About Ilika plc
Ilika is a global expert in the development of solid-state battery technology for electric vehicles, medical devices and consumer appliances. The Company's pioneering next-generation technologies aim to provide scalable, affordable alternatives to conventional batteries, to industries which need to incorporate a smaller, lighter, and safer power source in their products.
The Company has two product lines. Its Stereax batteries are designed for powering miniature medical implants, industrial wireless sensors and Internet of Things (IoT) applications and the Goliath large format batteries are designed for EV cars and cordless appliances.
Through its licensing business model, Ilika supplies its IP portfolio to both OEMs and manufacturing partners in exchange for a license fee and future royalties.
About Cirtec Medical
Cirtec Medical is a global leader in design, development, and manufacturing of complex Class II and III medical devices, specializing inactive implant systems, interventional devices, precision components, and thin film and microelectronics. Since 1987, Cirtec Medical has built extensive in-house capabilities that enable the company to serve as a single-source partner and collaborate with customers to transform their technology into innovative medical devices across a wide array of therapies, including cardiology, neurology, orthopedics and other minimally invasive device applications. Cirtec Medical's deep expertise in precision component design and manufacturing supports every stage of the product lifecycle, ensuring uncompromising quality and performance. With 11 global facilities and a vertically integrated approach, Cirtec Medical aims to expedite time to market, reduce risk, and accelerate revenue generation for our partners. Learn more at CirtecMed.com.